4005F Pharmaceutical thx for outpatient rxd
Also known as: osteoporosis therapy, bone protective medication
Performance measure indicating documentation that pharmacological therapy was prescribed for osteoporosis. Records prescription of bone-protective medications.
In Plain Language
medication to strengthen bones
Clinical Context
Quality measure for osteoporosis management in patients with fracture risk or diagnosed osteoporosis. Includes bisphosphonates, hormonal agents, or other bone-protective therapies.
RVU Information
CPT 4005F does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Documentation should include the clinical indication, service details, and any applicable performance metrics. Coverage may vary by payer — verify acceptance before billing.
Specialties
Frequently Asked Questions
What is CPT code 4005F?
CPT 4005F (Pharmaceutical thx for outpatient rxd) is a Other code. Performance measure indicating documentation that pharmacological therapy was prescribed for osteoporosis. Records prescription of bone-protective medications.
Who uses CPT code 4005F?
CPT 4005F is used by Orthopedic Surgery, Endocrinology, Internal Medicine. Quality measure for osteoporosis management in patients with fracture risk or diagnosed osteoporosis. Includes bisphosphonates, hormonal agents, or other bone-protective therapies.
When is CPT 4005F used?
Quality measure for osteoporosis management in patients with fracture risk or diagnosed osteoporosis. Includes bisphosphonates, hormonal agents, or other bone-protective therapies.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.